We are live on
!
Find out more
ITCI
Intra-Cellular Therapies Inc.
ITCI
ITCI
Delisted
ITCI was delisted on the 1st of April, 2025.
133 hedge funds and large institutions have $1.3B invested in Intra-Cellular Therapies Inc. in 2019 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 36 increasing their positions, 47 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
337% more capital invested
Capital invested by funds: $298M → $1.3B (+$1B)
29% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 24
6% more funds holding
Funds holding: 126 → 133 (+7)
23% less repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 47
53% less call options, than puts
Call options by funds: $260M | Put options by funds: $549M
Holders
133
Holders Change
+7
Holders Change %
+5.56%
% of All Funds
2.62%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.08%
New
31
Increased
36
Reduced
47
Closed
24
Calls
$260M
Puts
$549M
Net Calls
-$289M
Net Calls Change
-$278M
Top Buyers
| 1 |
CCM
Consonance Capital Management
New York
|
+$23.5M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$14.6M |
| 3 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$7.05M |
| 4 |
VMI
VHCP Management III
New York
|
+$6.9M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$2.84M |
Top Sellers
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$26.8M |
| 2 |
Millennium Management
New York
|
-$11.7M |
| 3 |
SC
Samlyn Capital
New York
|
-$11M |
| 4 |
Schroder Investment Management Group
London,
United Kingdom
|
-$8.11M |
| 5 |
ClearBridge Investments
New York
|
-$5.61M |
